Literature DB >> 17464978

Low incidence of HCV reinfection: exposure, testing frequency, or protective immunity?

Gregory J Dore, Joanne Micallef.   

Abstract

Mesh：

Year:  2007        PMID： 17464978     DOI： 10.1002/hep.21577

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  6 in total

Review 1.  Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities.

Authors:  Lisa Maher; Bethany White; Margaret Hellard; Annie Madden; Maria Prins; Thomas Kerr; Kimberly Page
Journal:  Vaccine       Date:  2010-09-09       Impact factor: 3.641

Review 2.  Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine.

Authors:  Jason Grebely; Maria Prins; Margaret Hellard; Andrea L Cox; William O Osburn; Georg Lauer; Kimberly Page; Andrew R Lloyd; Gregory J Dore
Journal:  Lancet Infect Dis       Date:  2012-05       Impact factor: 25.071

3.  Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection.

Authors:  Kimberly Page; William Osburn; Jennifer Evans; Judith A Hahn; Paula Lum; Alice Asher; Eric Delwart; Leslie Tobler; Andrea L Cox; Michael P Busch
Journal:  Clin Infect Dis       Date:  2012-10-22       Impact factor: 9.079

4.  Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.

Authors:  Kimberly Page; Judith A Hahn; Jennifer Evans; Stephen Shiboski; Paula Lum; Eric Delwart; Leslie Tobler; William Andrews; Lia Avanesyan; Stewart Cooper; Michael P Busch
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

5.  The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design.

Authors:  Peter Vickerman; Jason Grebely; Gregory J Dore; Rachel Sacks-Davis; Kimberly Page; David L Thomas; William O Osburn; Andrea L Cox; Campbell K Aitken; Matthew Hickman; Margaret Hellard
Journal:  J Infect Dis       Date:  2012-03-29       Impact factor: 5.226

6.  Prevalence of mixed genotype hepatitis C virus infections in the UK as determined by genotype-specific PCR and deep sequencing.

Authors:  A L McNaughton; V B Sreenu; G Wilkie; R Gunson; K Templeton; E C M Leitch
Journal:  J Viral Hepat       Date:  2018-02-21       Impact factor: 3.728
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.